Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 01, 2011 08:00 ET | Source: Cytomedix, Inc.

Cytomedix Submits 510(k) to FDA for Bone Marrow Aspirate Concentrate Indication for Angel System

GAITHERSBURG, Md., Sept. 1, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...
August 31, 2011 08:00 ET | Source: Cytomedix, Inc.

Cytomedix Provides Update on Reimbursement Reconsideration Request for Autologous PRP Gel

GAITHERSBURG, Md., Aug. 31, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...
August 15, 2011 16:05 ET | Source: Cytomedix, Inc.

Cytomedix Reports Second Quarter Financial Results

GAITHERSBURG, Md., Aug. 15, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...
August 09, 2011 08:30 ET | Source: Cytomedix, Inc.

Cytomedix to Host Second Quarter 2011 Financial Results Conference Call on Tuesday, August 16, 2011

GAITHERSBURG, Md., Aug. 9, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today...
August 01, 2011 08:30 ET | Source: Cytomedix, Inc.

Positive Data Demonstrating AutoloGel Provides Rapid Improvement in Healing of Complex Chronic Wounds Published in Advances in Skin and Wound Care

GAITHERSBURG, Md., Aug. 1, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...
July 20, 2011 16:30 ET | Source: Cytomedix, Inc.

Cytomedix Completes Two Convertible Note Financings

GAITHERSBURG, Md., July 20, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...
May 31, 2011 08:00 ET | Source: Cytomedix, Inc.

Cytomedix Submits Reimbursement Reconsideration Request to Centers for Medicare & Medicaid Services for Autologous PRP Gel

GAITHERSBURG, Md., May 31, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...
May 16, 2011 16:27 ET | Source: Cytomedix, Inc.

Cytomedix Reports First Quarter Financial Results

GAITHERSBURG, Md., May 16, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the Company), a leading developer of biologically active regenerative therapies for wound care, inflammation and...
May 11, 2011 07:47 ET | Source: Cytomedix, Inc.

Cytomedix to Host First Quarter 2011 Financial Results Conference Call on Tuesday, May 17, 2011

GAITHERSBURG, Md., May 11, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today...
May 02, 2011 08:00 ET | Source: Cytomedix, Inc.

Cytomedix Retires All Angel Acquisition Debt With New Loan and Equity Financing

GAITHERSBURG, Md., May 2, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...